The gene edits given to Chinese twins last year meant to immunize them against HIV may have failed in its purpose and created unintended mutations, scientists said Tuesday after the original research was made public for the first time.
Excerpts from the manuscript were released by the MIT Technology Review for the purpose of showing how Chinese biophysicist He Jiankui ignored ethical and scientific norms in creating the twins Lula and Nana, whose birth in late 2018 sent shockwaves through the scientific world.
He made expansive claims of a medical breakthrough that could "control the HIV epidemic," but it was not clear whether it had even been successful in its intended purpose -- immunizing the babies against the virus -- because the team did not in fact reproduce the gene mutation that confers this resistance.
A small percentage of people are born with immunity because of a mutation in a gene called CCR5 and it was this gene that He had claimed he had targeted using a powerful editing tool known as CRISPR which has revolutionized the field since bursting on the scene in 2012.
Fyodor Urnov, a genome-editing scientist at the University of California, Berkeley told the MIT Technology Review: "The claim they have reproduced the prevalent CCR5 variant is a blatant misrepresentation of the actual data and can only be described by one term: a deliberate falsehood.
"The study shows that the research team instead failed to reproduce the prevalent CCR5 variant." While the team targeted the right gene, they did not replicate the "Delta 32" variation required, instead creating novel edits whose effects aren't clear.
Moreover, CRISPR remains an imperfect tool because it can lead to unwanted or "off-target" edits, making its use in humans hugely controversial.
Here, the researchers claimed they had searched for such effects in the early-stage embryos and found just one -- but this glossed over the fact that it would be impossible to carry out a comprehensive search without inspecting each of the embryo's cells and thus destroying it.
Further ethical concerns included that the parents of the babies might have wanted to take part for the wrong reasons.
The father was HIV positive, which carries a significant social stigma in China and makes it almost impossible to have access to fertility treatment, even though a well-established technique known as "sperm washing" prevents the infection from being passed on to unborn children.
Their lack of access to any kind of fertility treatment may have motivated them to take part in the experiment despite the huge risks to their children, Jeanne O'Brien, a reproductive endocrinologist at Shady Grove Fertility told the MIT Technology Review.
He attempted to shop his manuscript around to prestigious journals including Nature and JAMA, but it remains unpublished.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
